Siasun Robot Brand Ranking
If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.
Siasun Robot

Siasun Robot

Wuhan Jinghong Technology Co., Ltd.
If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.
Brand Introduction

Wuhan Jinghong Technology Co., Ltd. was established in 2005 with a registered capital of 59.6 million yuan and is a national high-tech enterprise. The company's main business covers three major areas: biological immune in vitro diagnosis, home medical electronics, and medical imaging. The products are mainly used for the detection of tumors, cardiovascular and cerebrovascular diseases, eugenics, and other aspects; bedside diagnosis of blood sugar, blood pressure, fetal heart rate, and electrocardiogram; and medical images such as digital B-ultrasound, DR.

The company is headquartered in Wuhan Optics Valley Biocity, a national biological industry base, covering an area of ​​60 acres. The company is committed to "exploring the mysteries of life and serving the health of the public", and continues to focus on product and technological innovation in the fields of medical care, family health, public safety, etc. . It has 2 innovation fund projects of the Ministry of Science and Technology, 72 nationally authorized patents, 54 registration certificates for Class II and III medical devices, and 7 product CE certificates.

The company has the right to operate self-operated import and export, Internet B2C sales platform for drugs and medical devices. The products are promoted and used in OTC pharmacies, hospitals at all levels, and disease control centers, covering major cities across the country and remote areas such as Xinjiang, Tibet, and Inner Mongolia. The sales channels are mature. Stablize. Under the guidance of the national "Belt and Road" policy, we will continue to expand the international market and export to the Americas, Europe, the Middle East, Southeast Asia and Africa.

The company focuses on the product development strategy of "two highs and one long", namely high-tech content, high market capacity and long life cycle, and is deeply engaged in the field of in vitro diagnosis. The company is committed to becoming a leader in the domestic in vitro diagnostic industry (IVD) and realizing the company's industrial dream and Chinese dream.

Recommend Related Products

版权所有 © 宁波全贸信息技术有限公司 浙ICP备12012821号-1 浙B2-20200628

浙公网安备 33020902000078号